Sort by
Refine Your Search
-
Category
-
Country
-
Employer
- Center for Drug Evaluation and Research (CDER)
- King's College London
- National University of Singapore
- Zintellect
- Harvard University
- Nanyang Technological University
- Office of the Commissioner (OC)
- Queen's University Belfast;
- The University of Queensland
- University of Maryland, Baltimore
- University of Nottingham
- University of Oslo
- ADELAIDE UNIVERSITY
- Cardiff University
- Centre for European Policy Studies
- City of Hope
- Cori Institute of Molecular and Computational Metabolism
- DAAD
- Drexel University
- Eisbach Bio GmbH
- Ellison Institute of Technology
- IDAEA-CSIC
- Instituto de Investigação e Inovação em Saúde da Universidade do Porto (i3S)
- Life and Health Sciences Research Institute (ICVS), from the School of Medicine (EM) of the University of Minho
- Monash University
- National Center for Toxicological Research (NCTR)
- Northeastern University
- Purdue University
- QUEENS UNIVERSITY BELFAST
- SINGAPORE INSTITUTE OF TECHNOLOGY (SIT)
- The University of Alabama
- Universidade de Coimbra
- University of Alabama, Tuscaloosa
- University of Antwerp
- University of Birmingham
- University of Colorado
- University of Dundee
- University of Glasgow
- University of Michigan
- University of North Carolina at Chapel Hill
- University of Sydney
- University of Texas at Austin
- University of Washington
- Vanderbilt University
- Visterra, Inc.
- eQuest
- 36 more »
- « less
-
Field
-
disease targets. Our focus includes kidney, immune, and other hard-to-treat diseases. As a subsidiary of Otsuka Pharmaceutical Co., Ltd. of Japan, Visterra benefits from the agility of an innovative
-
, or global health policy. By contributing to high-impact research projects spanning international regulatory operations, emerging technology, and pharmaceutical market policy, you will develop a robust
-
: Doctorate. Additional qualifications based on assignment. Additional Required Department Minimum Qualifications: Ph.D. in molecular pharmacology and experimental therapeutics, pharmaceutics, biology
-
Campus About This Opportunity Join a globally connected research community at the University of Queensland and help shape the future of synthetic biology and pharmaceutical chemistry. As a Postdoctoral
-
: Doctorate. Additional qualifications based on assignment. Additional Required Department Minimum Qualifications: Ph.D. in molecular pharmacology and experimental therapeutics, pharmaceutics, biology
-
science, with fundamental or applied studies with relevance to the pharmaceutical and consumer healthcare (over-the-counter) industries. Students from Germany who are going abroad for a study project or
-
Center for Drug Evaluation and Research (CDER) | Silver Spring, Maryland | United States | about 15 hours ago
Research (CDER), Office of Pharmaceutical Quality (OPQ), The Office of Pharmaceutical Quality Research (OPQR), located at Silver Spring, Maryland. The Center for Drug Evaluation and Research (CDER) performs
-
international regulatory operations, emerging technology, and pharmaceutical market policy, you will develop a robust portfolio of analytical, writing, and collaborative skills. Engagement with FDA's global
-
» Biology Medical sciences » Medicine Technology » Biotechnology Chemistry Computer science Biological sciences » Nutritional sciences Technology » Pharmaceutical technology Mathematics » Statistics
-
interventions, or other complex long-term conditions. Working knowledge of clinical trial regulations and guidance, including International Council for Harmonisation of Technical Requirements for Pharmaceuticals